成人小脑髓母细胞瘤误诊为脑膜瘤1例
|
摘要
<正>髓母细胞瘤(medulloblastoma,MB)是一种恶性的,常见于儿童小脑的侵袭性胚胎性肿瘤,发病年龄高峰为7岁,70%MB发生在<16岁的青少年。80%成人MB发生在21~40岁年龄组,该肿瘤极少发生于50岁以上人群。本研究报道1例50岁女性患者在当地医院误诊为脑膜瘤,最后确诊为小脑MB病例,并就其诊断和鉴别诊断相关问题进行分析。1病例资料患者于2015年5月因"头阵发性憋胀20 d"就诊于当地医院,在全麻下行左枕开颅经小脑幕肿瘤切
引文
[1]潘冬梅,范国华,沈钧康,等.成人小脑髓母细胞瘤的MRI表现[J].中国医学计算机成像杂志,2015,21(3):201-204.
[2]林炳权,许乙凯,冯婕.非中线髓母细胞瘤的MRI诊断分析[J].医学影像学杂志,2013,23(5):661-664.
[3]谭仲伦,成官迅,郭晓婷.成人髓母细胞瘤MRI诊断及误诊分析[J].医学影像学杂志,2015,25(6):969-972.
[4]朱熠,成官迅,高茜,等.不典型髓母细胞瘤的MRI征象探讨[J].临床放射学杂志,2013,32(2):168-171.
[5]张夏玲,程海霞,汪寅.成人髓母细胞瘤伴肌原性分化[J].中国现代神经疾病杂志,2015,15(9):728-734.
[6]Benson R,Mallick S,Bhanu Prasad V,et al.Medullomyoblastoma treated with craniospinal radiation and adjuvant chemotherapy:Report of 4 cases and review of the literature[J].J Egypt Natl Canc Inst,2015,27(2):109-111.
[7]Fathaddin AA,Bakhash EA,Sabbagh AJ,et al.Large cell/anaplastic medulloblastoma with myogenic,melanotic and neuronal differentiation:a case report of a rare tumor[J].Indian J Pathol Microbiol,2014,57(2):294-297.
[8]Rattenberry W,Mcdonough CH,Burger PC,et al.Medulloblastoma with myogenic differentiation:long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation[J].J Neurooncol,2011,105(3):659-662.
[2]林炳权,许乙凯,冯婕.非中线髓母细胞瘤的MRI诊断分析[J].医学影像学杂志,2013,23(5):661-664.
[3]谭仲伦,成官迅,郭晓婷.成人髓母细胞瘤MRI诊断及误诊分析[J].医学影像学杂志,2015,25(6):969-972.
[4]朱熠,成官迅,高茜,等.不典型髓母细胞瘤的MRI征象探讨[J].临床放射学杂志,2013,32(2):168-171.
[5]张夏玲,程海霞,汪寅.成人髓母细胞瘤伴肌原性分化[J].中国现代神经疾病杂志,2015,15(9):728-734.
[6]Benson R,Mallick S,Bhanu Prasad V,et al.Medullomyoblastoma treated with craniospinal radiation and adjuvant chemotherapy:Report of 4 cases and review of the literature[J].J Egypt Natl Canc Inst,2015,27(2):109-111.
[7]Fathaddin AA,Bakhash EA,Sabbagh AJ,et al.Large cell/anaplastic medulloblastoma with myogenic,melanotic and neuronal differentiation:a case report of a rare tumor[J].Indian J Pathol Microbiol,2014,57(2):294-297.
[8]Rattenberry W,Mcdonough CH,Burger PC,et al.Medulloblastoma with myogenic differentiation:long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation[J].J Neurooncol,2011,105(3):659-662.